Phillips-Medisize has acquired exclusive ownership of patents for a mini-tablet dispenser from a global pharmaceutical company.
“The mini-tablet dispenser will be valuable in pediatrics, geriatrics and oncology where patients often require highly flexible oral dosing based on age, weight and other variables,” said Matt Jennings, chief executive of Phillips-Medisize. “Furthermore, in smaller patient populations the option to flexibly count to combine incremental mini-tablet doses offers an advantage over preparing multiple fixed oral tablet dose strengths.”
The mini-tablet dispenser differentiates itself from other systems that predominantly rely on volumetric measuring principles. With the assistance of this dispenser mounted on top of a standard tablet bottle, a patient or caregiver will be able to count and dispense mini-tablets in predetermined amounts from one to twenty tablets. The mini-tablet dispenser enables the user to visually confirm the measured tablet count number before dispensing and is designed to minimise damage or crushing of the mini-tablets during dispensing.
Phillips-Medisize is aiming to make the dispenser available to pharmaceutical companies globally in early 2020.